To understand the biology of diseased organs, researchers can use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types.
The Swiss drugmaker has clearly noticed the genomic profiling group’s ability to personalise cancer care, now that it will take complete ownership of the company.
Elizabeth Holmes, Founder of disgraced biotech Theranos, and her former COO, Ramesh ‘Sunny’ Balwani, have been indicted with alleged wire fraud schemes in the state of California.
Using genome-wide genetic approaches, researchers systematically screened for the loss of an additional gene that could rescue a genetic disease, and found it.
Sometimes a new company catches the eye, and this week that company is nference, a Cambridge MA-based start-up developing AI technology to discover and develop drugs more effectively. AI is no longer new in this space, so why does nference grab our attention?
A patient with metastatic breast cancer has made a dramatic recovery after receiving a personalised therapy using her own cells.
A 21-gene test performed on tumours could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study.
Japanese scientists now have permission to treat people who have heart disease with cells produced by a revolutionary reprogramming technique, which excites researchers. But some fear the therapy will be rushed to market.